Athira Pharma has been on a bumpy road in recent years, and now the company is restructuring and shedding weight to try to ...

Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is the most common degenerative motor neuron disease ...

Synchron has announced one of its patients with ALS is now able to control devices using only his mind with the company's ...

Researchers implanted sensors in the brain of a man with severely impaired speech due to amyotrophic lateral sclerosis (ALS). The man was able to ...

Familial ALS (FALS) runs in families. About 5% to 10% of people with amyotrophic lateral sclerosis have this type. Changes to a gene cause FALS. Parents pass the faulty gene to their children.

A patient with a degenerative disease was able to command Amazon's Alexa digital assistant with his mind, the company behind ...

Fasudil is under clinical development by Woolsey Pharmaceuticals and currently in Phase II for Amyotrophic Lateral Sclerosis.

Siplizumab is under clinical development by ITB-Med and currently in Phase I for Amyotrophic Lateral Sclerosis.

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder that is marked by fasciculation, spasticity and progressive weakness of muscles, and results in difficulty speaking ...

Ahmedabad: Zydus, a discovery-based, global pharmaceutical company, announced the completion of its Phase II(a) clinical ...